Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Analysis 2013-2018 and Forecast 2019-2024

May 2019 | 81 pages | ID: GDA5B65C508EN
99Strategy

Abstracts

SNAPSHOT

The global Lysosomal Acid Lipase Deficiency (LAAL) Treatment market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Lysosomal Acid Lipase Deficiency (LAAL) Treatment by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Enzyme Replacement Therapy
• Kidney Transplantation
• Stem Cell Transplantation

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

• AstraZeneca plc
• Merck & Co., Inc
• Pfizer, Inc.
• Alexion Pharmaceutical Inc
• Lonza Group Ltd.
• hermo Fisher Scientific
• Teva Pharmaceutical Industries Ltd.

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

• Wolman Disease
• Cholesterol Ester Storage Disease (CESD)

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
• Asia-Pacific (China, India, Japan, Southeast Asia etc.)
• South America (Brazil, Argentina etc.)
• Middle East & Africa (Saudi Arabia, South Africa etc.)

Contents

1 INDUSTRY OVERVIEW

1.1 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Industry
  1.1.1 Overview
  1.1.2 Development of Lysosomal Acid Lipase Deficiency (LAAL) Treatment
1.2 Market Segment
  1.2.1 Upstream
  1.2.2 Downstream
1.3 Cost Analysis

2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 LYSOSOMAL ACID LIPASE DEFICIENCY (LAAL) TREATMENT MARKET BY TYPE

3.1 By Type
  3.1.1 Enzyme Replacement Therapy
  3.1.2 Kidney Transplantation
  3.1.3 Stem Cell Transplantation
3.2 Market Size
3.3 Market Forecast

4 MAJOR COMPANIES LIST

4.LYSOSOMAL ACID LIPASE DEFICIENCY (LAAL) TREATMENT ASTRAZENECA PLC (COMPANY PROFILE, SALES DATA ETC.)

4.2 Merck & Co., Inc (Company Profile, Sales Data etc.)
4.3 Pfizer, Inc. (Company Profile, Sales Data etc.)
4.4 Alexion Pharmaceutical Inc (Company Profile, Sales Data etc.)
4.5 Lonza Group Ltd. (Company Profile, Sales Data etc.)
4.6 hermo Fisher Scientific (Company Profile, Sales Data etc.)
4.7 Teva Pharmaceutical Industries Ltd. (Company Profile, Sales Data etc.)

5 MARKET COMPETITION

5.1 Company Competition
5.2 Regional Market by Company

6 DEMAND BY END MARKET

6.1 Demand Situation
  6.1.1 Demand in Wolman Disease
  6.1.2 Demand in Cholesterol Ester Storage Disease (CESD)
6.2 Regional Demand Comparison
6.3 Demand Forecast

7 REGION OPERATION

7.1 Regional Production
7.2 Regional Market
7.3 by Region
  7.3.1 North America
    7.3.1.1 Overview
    7.3.1.2 by Country (U.S., Canada, Mexico)
  7.3.2 Europe
    7.3.2.1 Overview
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  7.3.3 Asia-Pacific
    7.3.3.1 Overview
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  7.3.4 South America
    7.3.4.1 Overview
    7.3.4.2 by Country (Brazil, Argentina etc.)
  7.3.5 Middle East & Africa
    7.3.5.1 Overview
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast

8 MARKETING & PRICE

8.1 Price and Margin
  8.1.1 Price Trends
  8.1.2 Factors of Price Change
  8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel

9 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Upstream Segment of Lysosomal Acid Lipase Deficiency (LAAL) Treatment
Table Application Segment of Lysosomal Acid Lipase Deficiency (LAAL) Treatment
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market 2013-2024, by Application, in USD Million
Table Major Company List of Enzyme Replacement Therapy
Table Major Company List of Kidney Transplantation
Table Major Company List of Stem Cell Transplantation
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market 2013-2018, by Type, in USD Million
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market 2013-2018, by Type, in Volume
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Forecast 2019-2024, by Type, in USD Million
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Forecast 2019-2024, by Type, in Volume
Table AstraZeneca plc Overview List
Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of AstraZeneca plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co., Inc Overview List
Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of Merck & Co., Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer, Inc. Overview List
Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alexion Pharmaceutical Inc Overview List
Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of Alexion Pharmaceutical Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lonza Group Ltd. Overview List
Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of Lonza Group Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table hermo Fisher Scientific Overview List
Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of hermo Fisher Scientific (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd. Overview List
Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Business Operation of Teva Pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Sales Revenue 2013-2018, by Company, in USD Million
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Sales Revenue Share, by Company, in USD Million
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Sales Volume 2013-2018, by Company, in Volume
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Sales Volume Share 2013-2018, by Company, in Volume
Table Major Consumers List and Overview
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Demand Forecast 2019-2024, by Application, in USD Million
Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Demand Forecast 2019-2024, by Application, in Volume
Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Production 2013-2018, by Region, in USD Million
Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Production 2013-2018, by Region, in Volume
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market 2013-2018, by Region, in USD Million
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share 2013-2018, by Region, in USD Million
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market 2013-2018, by Region, in Volume
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share 2013-2018, by Region, in Volume
Table North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in USD Million
Table North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in Volume
Table Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in USD Million
Table Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in Volume
Table Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in Volume
Table South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in USD Million
Table South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in Volume
Table Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size 2013-2018, by Country, in Volume
Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Forecast 2019-2024, by Region, in USD Million
Table Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Forecast 2019-2024, by Region, in Volume
Table Price Factors List

List Of Figures

LIST OF FIGURES

Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Growth 2013-2018, by Type, in USD Million
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Growth 2013-2018, by Type, in Volume
Figure North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Concentration, in 2018
Figure Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Market Concentration, in 2018
Figure Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment MMarket Concentration, in 2018
Figure South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Concentration, in 2018
Figure Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Concentration, in 2018
Figure Lysosomal Acid Lipase Deficiency (LAAL) Treatment Demand in Wolman Disease, 2013-2018, in USD Million
Figure Lysosomal Acid Lipase Deficiency (LAAL) Treatment Demand in Wolman Disease, 2013-2018, in Volume
Figure Lysosomal Acid Lipase Deficiency (LAAL) Treatment Demand in Cholesterol Ester Storage Disease (CESD), 2013-2018, in USD Million
Figure Lysosomal Acid Lipase Deficiency (LAAL) Treatment Demand in Cholesterol Ester Storage Disease (CESD), 2013-2018, in Volume
Figure North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in USD Million
Figure North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in Volume
Figure Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in USD Million
Figure Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in Volume
Figure Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in Volume
Figure South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in USD Million
Figure South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in Volume
Figure Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Growth 2013-2018, in Volume
Figure Marketing Channels Overview